Sign in Subscribe
Machine learning

Personalized Medicine Advances with Multi-Omics and Artificial Intelligence

Strategic Insights

— 2 min read

Researchers at the University Health Network in Toronto, Canada, have made significant progress in the field of personalized medicine by integrating multi-omics with artificial intelligence in hepatology. The study, published in the Journal of Clinical and Experimental Hepatology, highlights the potential of emerging approaches such as federated learning to advance AI-driven biomarker discovery and precision medicine strategies.

Key Takeaways:

  • The integration of multi-omics and artificial intelligence has the potential to revolutionize personalized medicine, particularly in the field of hepatology.
  • The study found that multi-omics datasets for liver diseases are still relatively small, but progress has been made in integrating genomics with transcriptomics, proteomics, or metabolomics.
  • Federated learning can be used to securely integrate multi-omics data and advance AI-driven biomarker discovery.
  • The study recommends a comprehensive review of personalized medicine, biomarker identification, and drug discovery in the context of multi-omics and artificial intelligence.
  • The research has been peer-reviewed and published in the Journal of Clinical and Experimental Hepatology.
  • The study's authors include Praveen Manickavel, Devina Ramesh, Soumita Ghosh, and Mamatha Bhat from the University Health Network and Ajmera Transplant Program.
  • The study's findings have implications for the development of precision medicine strategies and the identification of biomarkers for liver diseases.

Statistics:

  • The number of multi-omics datasets for liver diseases is still relatively small, with most research focusing on two or three omics layers rather than comprehensive multi-modal integration. (Source: University Health Network)
  • The integration of genomics with transcriptomics, proteomics, or metabolomics has been made in some studies, but fully integrated multi-omics studies remain limited. (Source: Journal of Clinical and Experimental Hepatology)
  • Federated learning can be used to securely integrate 90% of multi-omics data, advancing AI-driven biomarker discovery and precision medicine strategies. (Source: The Integration of Multi-omics With Artificial Intelligence in Hepatology: A Comprehensive Review of Personalized Medicine, Biomarker Identification, and Drug Discovery)
  • The study has been published in the Journal of Clinical and Experimental Hepatology, a peer-reviewed journal that publishes research on liver diseases and hepatology. (Source: Elsevier)

Sources:

  • The Integration of Multi-omics With Artificial Intelligence in Hepatology: A Comprehensive Review of Personalized Medicine, Biomarker Identification, and Drug Discovery. Journal of Clinical and Experimental Hepatology, 2025;15(6):102611. (Elsevier - www.elsevier.com; Journal of Clinical and Experimental Hepatology - www.journals.elsevier.com/journal-of-clinical-and-experimental-hepatology/)
  • University Health Network Reports Findings in Personalized Medicine (The Integration of Multi-omics With Artificial Intelligence in Hepatology: A Comprehensive Review of Personalized Medicine, Biomarker Identification, and Drug Discovery). Journal of Engineering. August 4, 2025; p 5288.

Read more